Deal History
Über uns
Die Firma
Team
Büros
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Aktienanalyse
Growth Equity
IPO Strategie und Vorbereitung
Industries
Business Services
Consumer & Internet
Industrial Technology
Healthcare
Software
Energy & Infrastructure
Karriere
Events
Insights
News
Company News
Deal News
In den Medien
Newsletter
Kontakt
Newsletter
DE
INT
DA
FR
SV
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company News
Deal News
Equity Research
Events
In den Medien
Insights
Märkte
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pila Pharma
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
12 Apr 2023
Carlsquare weekly market letter: Can Q1 earnings provide the final push to the upside?
Equity Research
Carlsquare
05 Apr 2023
Mrkt BUZZ Zinzino: Important Central Europe continues to deliver
Equity Research
Zinzino
05 Apr 2023
Carlsquare weekly market letter: The worst may be over
Equity Research
Carlsquare
03 Apr 2023
Mrkt BUZZ ALM Equity: New owner in Klövern and upcoming new share issues
Equity Research
ALM Equity
01 Apr 2023
Research update Zazz Energy, Q4 2022: Possible upside in the stock, but significant risk
Equity Research
31 Mrz 2023
First impression Zazz Energy, Q4 2022: Large write-downs and continued production standstill
Equity Research
30 Mrz 2023
Mrkt BUZZ Risk Intelligence: The DHL deal, a great opportunity for upselling
Equity Research
Risk Intelligence
29 Mrz 2023
Equity research Biosergen: Plans for speedy development of lead candidate
Equity Research
Biosergen
29 Mrz 2023
Swedish Real Estate Equity Snapshot
Equity Research
29 Mrz 2023
Carlsquare weekly market letter: Building energy, boiling and rotation beneath the surface
Equity Research
Carlsquare
22 Mrz 2023
Carlsquare weekly market letter: Are we back to 1929 or 2008?
Equity Research
Carlsquare
20 Mrz 2023
Initiation of coverage, Biosergen: Make antifungals great again
Equity Research
Biosergen
20 Mrz 2023
Initiation of coverage Future Gaming: Reversed acquisition boosts Future Gaming
Equity Research
15 Mrz 2023
Carlsquare weekly market letter: Tech rebounds as Fed trembles
Equity Research
Carlsquare
15 Mrz 2023
Research Update Kancera, Q4 2022: Start of cancer trial expected shortly
Equity Research
13 Mrz 2023
Research Update InCoax, Q4 2022: Positive follow-up orders from US operator
Equity Research
InCoax
10 Mrz 2023
First Impression InCoax, Q4 2022: Better than expected revenues, but low gross margin
Equity Research
InCoax
08 Mrz 2023
Carlsquare weekly market letter: Big Evening Star in S&P 500
Equity Research
Carlsquare
06 Mrz 2023
Research update Zinzino, Q4 2022: Profit growth in the cards for 2023
Equity Research
Zinzino
06 Mrz 2023
Research update Risk Intelligence, Q4 2022: Large global customers can give a boost
Equity Research
Risk Intelligence
1
…
25
26
27
28
29
…
64